Wegovy Injection

Wegovy is a prescription-only weight loss medication used alongside a reduced-calorie diet and increased physical activity to help manage weight in adults who are obese (BMI ≥30) or overweight (BMI ≥27) with at least one weight-related condition (such as type 2 diabetes, high blood pressure, or high cholesterol).

Wegovy contains semaglutide, a medicine that mimics the effects of a natural hormone called GLP-1. It works by reducing appetite, slowing gastric emptying, and increasing feelings of fullness, which leads to a reduction in calorie intake and sustained weight loss over time.

How to use:

• Wegovy is given as a once-weekly injection under the skin (subcutaneous), in the abdomen, thigh, or upper arm.

• Start with 0.25mg once weekly for the first 4 weeks, gradually increasing the dose every 4 weeks as advised, up to a maintenance dose of 2.4mg once weekly.

• Always follow the specific dosing schedule and instructions provided by your prescriber.

• If you miss a dose and it’s within 5 days of your scheduled injection, take it as soon as possible. Otherwise, skip the dose and take the next injection as planned.

Precautions:

• Do not use if you are allergic to semaglutide or any of the ingredients in Wegovy.

• Not suitable for use in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2 (MEN 2).

• Speak to a doctor or pharmacist before use if you have a history of pancreatitis, gallbladder problems, or are taking other medicines for diabetes or weight loss.

• Common side effects include nausea, vomiting, diarrhoea, constipation, headache, and fatigue — these usually lessen over time.

• Serious side effects are rare but may include pancreatitis, gallstones, or kidney problems.

• Not recommended during pregnancy or breastfeeding.

Always read the patient information leaflet before use.